Sageworth Trust Company of South Dakota’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-90
Closed -$15.2K 167
2023
Q1
$15.2K Hold
90
0.04% 89
2022
Q4
$15K Hold
90
0.03% 84
2022
Q3
$17K Sell
90
-31
-26% -$6.54K 0.04% 71
2022
Q2
$20K Buy
121
+20
+20% +$3.16K 0.04% 86
2022
Q1
$19K Sell
101
-72
-42% -$13.7K 0.04% 117
2021
Q4
$46K Buy
+173
New +$46.6K 0.07% 107

Other funds holding RGEN

Sageworth Trust Company of South Dakota's RGEN Position: Q2 2023 in Review

Sageworth Trust Company of South Dakota sold out of Repligen (RGEN) in Q2 2023, closing a stake of 90 shares — an estimated $15.2K sold.

Sageworth Trust Company of South Dakota first reported a position in RGEN in Q4 2021 and held it in 6 quarters. The position peaked at $46K in Q4 2021. 448 funds tracked by Wall St. Rank hold RGEN as of Q2 2023.

  • Sageworth Trust Company of South Dakota reported no remaining Repligen position as of Q2 2023 after selling out during the quarter.
  • Sageworth Trust Company of South Dakota sold 90 Repligen shares in Q2 2023, an estimated $15.2K.
  • Sageworth Trust Company of South Dakota first reported a position in Repligen in Q4 2021 and held it in 6 quarters.
  • Sageworth Trust Company of South Dakota's Repligen position peaked at $46K in Q4 2021.
  • 448 funds tracked by Wall St. Rank held Repligen as of Q2 2023.

Based on Sageworth Trust Company of South Dakota's 13F filing for Q2 2023, filed 3 Aug 2023.